Skip to main content
  • COMPARE Trial: DCBs with Low- or High-Dose Paclitaxel Show Similar Benefit in Fem-Pop Lesions at 2 Years

    Low- and high-dose paclitaxel-coated balloons (PCBs) show sustained treatment benefit for femoropopliteal lesions at 2-year follow-up, according to new results from the COMPARE trial.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details